优化发酵条件和媒介组件,以获得由Streptomyces sp.产生的色素. 在891-B6中,我们可以使用891-B6
Zhe Hu1,2,3, Qiangang Weng1,2,3, Zhehui Cai1,2,3
1School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, 310014, China.
BMC microbiology
|April 6, 2024
概括
优化发酵条件和介质组件显著增加了克里索米辛A (CA) 的产量. 这项研究使用Streptomyces sp.提高了60%的CA产量. 在891-B6.6.中使用.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 发酵技术的发酵技术
背景情况:
- 素A (CA) 是一种来自海洋细菌的强效抗生素和抗癌剂.
- 这种菌株是Streptomyces sp. 891-B6是一种UV诱导的突变,与其野生类型相比,它表现出增强的CA产量.
- 优化工作对于提高这种有价值化合物的产量至关重要.
研究的目的:
- 为了优化发酵条件,提高色素A (CA) 产量.
- 确定最佳的介质组件,以最大限度地提高CA产量.
- 为了验证改进的CA生产,以便进行潜在的扩展.
主要方法:
- 为了确定最佳的发酵参数,进行了单向实验.
- 使用响应表面方法来确定理想的营养度.
- 进行了验证测试,以确认产量改善.
主要成果:
- 最佳发酵条件包括12天,5天的种子年龄,5%的注射剂,200毫升体积和pH值6.5.
- 最佳的介质成分被确定为葡萄糖 (39.283 g/L),玉米粉 (20.662 g/L),大豆粉 (15.480 g/L) 和CaCO3 (2.000 g/L).
- 最大CA产量达到了1601.9±56.7 mg/L.
结论:
- 优化的发酵过程导致CA产量显著增加了60%.
- 这些发现为工业规模生产色素A.提供了坚实的基础.
- 菌株891-B6显示出大量抗生素制造的巨大潜力.
相关概念视频
01:22Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
01:30Designing Growth Media for Bioreactors
78
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
78
01:28Methods of Medium Optimization
69
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
69
01:14Scale-Up Processes
102
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
102
01:27Upstream Processing
96
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
96
01:27Production of Antibiotics
258
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
258